172 related articles for article (PubMed ID: 1680063)
1. Characterization of an accessory binding area in the histamine H2 receptor.
Orsetti M; Sorba G
Eur J Pharmacol; 1991 Jul; 207(3):259-65. PubMed ID: 1680063
[TBL] [Abstract][Full Text] [Related]
2. Histamine H2-receptor blocking activity of ranitidine and lamtidine analogues containing aminomethyl-substituted aliphatic systems.
Orsetti M
Agents Actions; 1988 Dec; 25(3-4):291-5. PubMed ID: 2905866
[TBL] [Abstract][Full Text] [Related]
3. Relation between pharmacological response and receptor binding with histamine blocking drugs. Irreversible antagonism of three analogues of mifentidine on right atrium and cerebral cortex of the guinea-pig.
Kramer K; Bast A; Timmerman H
Agents Actions; 1987 Jun; 21(1-2):41-8. PubMed ID: 2888281
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological profile of new histamine H2-receptor antagonists related to cimetidine, ranitidine and lamtidine.
Orsetti M; Sorba G
J Pharm Pharmacol; 1988 Jan; 40(1):31-4. PubMed ID: 2896770
[TBL] [Abstract][Full Text] [Related]
5. Action of ebrotidine, ranitidine and cimetidine on the specific binding to histamine H1- and H2-receptors.
Agut J; Sánchez JC; Sacristán A; Ortiz JA
Arzneimittelforschung; 1997 Apr; 47(4A):447-9. PubMed ID: 9205741
[TBL] [Abstract][Full Text] [Related]
6. SAR studies on H2 antagonists containing alkylamino substituted 1,2, 5-thiadiazole 1-oxide moieties.
Di Stilo A; Cena C; Lolli M; Sorba G; Gasco A; Bertaccini G; Pozzoli C; Adami M; Coruzzi G
Farmaco; 1998; 53(8-9):536-40. PubMed ID: 10081815
[TBL] [Abstract][Full Text] [Related]
7. Specific binding of 3H-tiotidine to histamine H2 receptors in guinea pig cerebral cortex.
Gajtkowski GA; Norris DB; Rising TJ; Wood TP
Nature; 1983 Jul 7-13; 304(5921):65-7. PubMed ID: 6135157
[TBL] [Abstract][Full Text] [Related]
8. Time-dependent interaction of a new H2-receptor antagonist, IT-066, with the receptor in the atria of guinea pig.
Muramatsu M; Hirose-Kijima H; Aihara H; Otomo S
Jpn J Pharmacol; 1991 Sep; 57(1):13-23. PubMed ID: 1686920
[TBL] [Abstract][Full Text] [Related]
9. Structure-activity characterization of an H2-receptor antagonist, 3-amino-4-[4-[4-(1-piperidinomethyl)-2-pyridyloxy]-cis-2-++ +butenylamino]- 3-cyclobutene-1,2-dione hydrochloride (T-066), involved in the insurmountable antagonism against histamine-induced positive chronotropic action in guinea pig atria.
Kijima H; Isobe Y; Muramatsu M; Yokomori S; Suzuki M; Higuchi S
Biochem Pharmacol; 1998 Jan; 55(2):151-7. PubMed ID: 9448737
[TBL] [Abstract][Full Text] [Related]
10. Combined histamine H1/H2 receptor antagonists: part II. Pharmacological hybrids with pheniramine- and tiotidine-like substructures.
Wolf C; Schulze FR; Buschauer A; Schunack W
Eur J Pharm Sci; 1998 Jul; 6(3):187-96. PubMed ID: 9795053
[TBL] [Abstract][Full Text] [Related]
11. Conformational requirements for histamine H2-receptor inhibitors: a structure-activity study of phenylene analogues related to cimetidine and tiotidine.
Hoffman JM; Pietruszkiewicz AM; Habecker CN; Phillips BT; Bolhofer WA; Cragoe EJ; Torchiana ML; Lumma WC; Baldwin JJ
J Med Chem; 1983 Feb; 26(2):140-4. PubMed ID: 6131129
[TBL] [Abstract][Full Text] [Related]
12. New ranitidine analogues containing the 2-aminobenzimidazole moiety: in vivo and in vitro histamine H2-receptor blocking activity.
Orsetti M; Oggero L
Agents Actions; 1988 Jun; 24(1-2):109-13. PubMed ID: 2900598
[TBL] [Abstract][Full Text] [Related]
13. [(3) H]UR-DE257: development of a tritium-labeled squaramide-type selective histamine H2 receptor antagonist.
Baumeister P; Erdmann D; Biselli S; Kagermeier N; Elz S; Bernhardt G; Buschauer A
ChemMedChem; 2015 Jan; 10(1):83-93. PubMed ID: 25320025
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological profiles of the new histamine H2-receptor antagonist N-ethyl-N'-[3-[3-(piperidinomethyl)phenoxy] propyl] urea.
Sekiguchi H; Hamada K; Kobayashi F; Taga F; Uchida H
Arzneimittelforschung; 1993 Feb; 43(2):129-33. PubMed ID: 8096132
[TBL] [Abstract][Full Text] [Related]
15. Combined histamine H1/H2 receptor antagonists: part I. Pharmacological hybrids with pheniramine- and roxatidine-like substructures.
Schulze FR; Buschauer A; Schunack W
Eur J Pharm Sci; 1998 Jul; 6(3):177-86. PubMed ID: 9795048
[TBL] [Abstract][Full Text] [Related]
16. Heterologous expression of rat epitope-tagged histamine H2 receptors in insect Sf9 cells.
Beukers MW; Klaassen CH; De Grip WJ; Verzijl D; Timmerman H; Leurs R
Br J Pharmacol; 1997 Nov; 122(5):867-74. PubMed ID: 9384502
[TBL] [Abstract][Full Text] [Related]
17. In vitro histamine H2-antagonist activity of the novel compound HUK 978.
Coombes JD; Norris DB; Rising TJ; Ross BC; Steward A
Life Sci; 1985 Nov; 37(18):1711-8. PubMed ID: 3840559
[TBL] [Abstract][Full Text] [Related]
18. [Studies on histamine H2-receptor antagonistic property of FRG-8813, a novel anti-ulcer drug].
Inaba N; Shibata M; Onodera S; Tanaka M; Suzuki T; Yamaura T; Ohnishi H
Nihon Yakurigaku Zasshi; 1995 Apr; 105(4):231-41. PubMed ID: 7774860
[TBL] [Abstract][Full Text] [Related]
19. Effect of mifentidine on histamine-stimulated human atrium "in vitro": comparison with ranitidine and cimetidine.
Poli E; Medici D; Contini GA; Bertaccini G
Arch Int Pharmacodyn Ther; 1985 Feb; 273(2):221-5. PubMed ID: 2860879
[TBL] [Abstract][Full Text] [Related]
20. Characterization of histamine receptors mediating the stimulation of cyclic AMP accumulation in rabbit cerebral cortical slices.
Al-Gadi M; Hill SJ
Br J Pharmacol; 1985 Aug; 85(4):877-88. PubMed ID: 2994788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
